A View of Medicaid Today and a Look Ahead: Balancing Access, Budgets and Upcoming Changes
This report highlights key policy priorities and issues state Medicaid programs focused on in FY 2025 and are prioritizing in FY 2026.
Read More
Medicaid Enrollment & Spending Growth: FY 2025 & 2026
This brief analyzes Medicaid enrollment and spending trends for FY 2025 and FY 2026, based on data provided by state Medicaid directors as part of the 25th annual survey of Medicaid directors.
State Medicaid Officials Project Flat Enrollment Post Unwinding but Increased Spending and Budget Pressures, as States Prepare for Impact of Federal Medicaid Policy Changes
As states completed the “unwinding” of pandemic-era continuous coverage, Medicaid enrollment fell 7.6% in FY 2025 and is expected to be largely flat in FY 2026, according to KFF’s 25th annual Medicaid Budget Survey. At the same time, total Medicaid spending grew by 8.6% in FY 2025 and is expected to grow by 7.
Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable?
That is the topic of a recent BioSpace article titled “How Effective Will TrumpRx and Other Direct-to-Consumer Drug Pricing Initiatives Be?” A am quoted in the article as follows: While [direct-to-consumer] DTC has been a growing trend in biopharma for nearly two years now—Lilly launched LillyDirect in January 2024—the number of drugmakers looking to sell their…
Cigna Launches Mental Health Collaboration with Headspace
Cigna Healthcare has partnered with Headspace to offer over 7 million members access to Headspace’s digital mental health tools. The post Cigna Launches Mental Health Collaboration with Headspace appeared first on MedCity News.
Novel Novartis Malaria Drug Shows Promise to Become New Asset Against Resistant Strains
Phase 3 results for the Novartis malaria drug “GanLum” show it was comparable to the standard of care and led to cure rates that top the threshold recommended by the World Health Organization. If approved, this new combination drug would become the first novel malaria therapy in more than 25 years. The post Novel Novartis…
The 340B Program’s New Rebate Pilot Won’t Fix Its Problems
The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with a major lack of transparency about how savings are used to benefit patients. As HRSA launches a new rebate-based model meant to boost oversight,…
Tracking Key HHS Public Health Policy Actions Under the Trump Administration
This resource chronologically lists and briefly describes key actions taken by the Trump Administration through the Department of Health and Human Services (HHS) that affect public health in the U.S. The actions are listed in the order in which they were first issued, reported or announced.
Turning AI Insights into Meaningful Action: The Future of Healthcare Navigation
[Sponsored] The confluence of AI and predictive analytics is rapidly transforming healthcare and benefits management, shifting the focus from reactive automation to proactive anticipation. The post Turning AI Insights into Meaningful Action: The Future of Healthcare Navigation appeared first on MedCity News.
Combining Ketamine and Deep TMS: A New Frontier in Treating Depression
Emerging evidence suggests that combining these interventions may enhance treatment outcomes and provide options for patients who have not responded to traditional therapies. The post Combining Ketamine and Deep TMS: A New Frontier in Treating Depression appeared first on MedCity News.